SK1172000A3 - Method and compositions for treating late phase allergic reactions and inflammatory diseases - Google Patents
Method and compositions for treating late phase allergic reactions and inflammatory diseases Download PDFInfo
- Publication number
- SK1172000A3 SK1172000A3 SK117-2000A SK1172000A SK1172000A3 SK 1172000 A3 SK1172000 A3 SK 1172000A3 SK 1172000 A SK1172000 A SK 1172000A SK 1172000 A3 SK1172000 A3 SK 1172000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- ulmwh
- antigen
- allergic
- reactions
- Prior art date
Links
- 0 OC1C(C2)C2C*1 Chemical compound OC1C(C2)C2C*1 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/904,565 US5980865A (en) | 1995-08-18 | 1997-08-04 | Method for treating late phase allergic reactions and inflammatory diseases |
PCT/US1998/016111 WO1999006025A1 (en) | 1997-08-04 | 1998-08-04 | Method and compositions for treating late phase allergic reactions and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SK1172000A3 true SK1172000A3 (en) | 2001-03-12 |
Family
ID=25419368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK117-2000A SK1172000A3 (en) | 1997-08-04 | 1998-08-04 | Method and compositions for treating late phase allergic reactions and inflammatory diseases |
Country Status (26)
Country | Link |
---|---|
US (2) | US5980865A (da) |
EP (1) | EP1003479B1 (da) |
JP (1) | JP2001511439A (da) |
KR (1) | KR100551773B1 (da) |
CN (1) | CN1092049C (da) |
AR (1) | AR005221A1 (da) |
AT (1) | ATE323500T1 (da) |
AU (1) | AU8684698A (da) |
BR (1) | BR9811823A (da) |
CA (1) | CA2298445C (da) |
DE (1) | DE69834256T2 (da) |
DK (1) | DK1003479T3 (da) |
ES (1) | ES2260843T3 (da) |
HK (1) | HK1030370A1 (da) |
HU (1) | HUP0003013A3 (da) |
IL (1) | IL134230A0 (da) |
NO (1) | NO20000558L (da) |
NZ (1) | NZ502498A (da) |
PL (1) | PL191796B1 (da) |
PT (1) | PT1003479E (da) |
RU (1) | RU2209624C2 (da) |
SK (1) | SK1172000A3 (da) |
TW (1) | TW585771B (da) |
UA (1) | UA75022C2 (da) |
WO (1) | WO1999006025A1 (da) |
ZA (1) | ZA986890B (da) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6984667B2 (en) * | 1998-04-08 | 2006-01-10 | Theta Biomedical Consulting And Development Co. | Synergistic proteoglycan compositions for inflammatory conditions |
US7799766B2 (en) * | 1998-04-08 | 2010-09-21 | Theta Biomedical Consulting & Development Co., Inc. | Composition for treating hormonally-dependent cancers |
US20080153761A1 (en) * | 1998-04-08 | 2008-06-26 | Theoharides Theoharis C | Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
US7906153B2 (en) * | 1998-04-08 | 2011-03-15 | Theta Biomedical Consulting & Development Co., Inc. | Anti-inflammatory compositions for treating multiple sclerosis |
US6689748B1 (en) * | 1998-04-08 | 2004-02-10 | Theoharis C. Theoharides | Method of treating mast cell activation-induced diseases with a proteoglycan |
US20050220909A1 (en) * | 2004-03-30 | 2005-10-06 | Theoharides Theoharis C | Composition for protection against superficial vasodilator flush syndrome |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
GB9917092D0 (en) | 1999-07-22 | 1999-09-22 | Ml Lab Plc | Treatment of angiogenesis-dependent conditions |
US20040230559A1 (en) * | 1999-08-09 | 2004-11-18 | Mark Newman | Information processing device and information processing method |
US20040224922A1 (en) * | 1999-08-26 | 2004-11-11 | Malcolm King | Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto |
GB0003048D0 (en) * | 2000-02-11 | 2000-03-29 | Dealler Stephen F | The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism |
SE0001631D0 (sv) * | 2000-05-04 | 2000-05-04 | Sahltech Ab | New use |
WO2001093846A2 (en) * | 2000-05-23 | 2001-12-13 | The Trustees Of Columbia University In The City Of New York | Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
PT1511466E (pt) | 2002-02-18 | 2009-01-16 | Ockham Biotech Ltd | Utilização de glicosaminoglicanos tais como heparina para o tratamento de desordens respiratórias tais como dpoc |
EP1494732B1 (en) | 2002-03-20 | 2008-01-30 | MannKind Corporation | Inhalation apparatus |
EP1539192A1 (en) * | 2002-04-24 | 2005-06-15 | Medicarb AB | Composition and kit for the treatment of inflammatory bowel diseases |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
WO2004084918A1 (ja) * | 2003-03-25 | 2004-10-07 | Sekisui Chemical Co., Ltd. | 皮膚止痒外用組成物 |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US7923043B2 (en) * | 2004-03-30 | 2011-04-12 | Theta Biomedical Consulting & Development Co., Inc. | Method for protecting humans against superficial vasodilator flush syndrome |
KR101273120B1 (ko) | 2004-08-20 | 2013-06-13 | 맨카인드 코포레이션 | 다이케토피페라진 합성의 촉매 작용 |
KR20130066695A (ko) | 2004-08-23 | 2013-06-20 | 맨카인드 코포레이션 | 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염 |
BRPI0515163A (pt) * | 2004-09-10 | 2008-07-08 | Pharmaorigin Aps | métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local |
TW200621794A (en) * | 2004-10-06 | 2006-07-01 | Akzo Nobel Nv | Pulmonary administration of an antithrombotic compound |
US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
IN2014DN09128A (da) | 2005-09-14 | 2015-07-10 | Mannkind Corp | |
US8057840B2 (en) * | 2006-01-25 | 2011-11-15 | Tate & Lyle Ingredients Americas Llc | Food products comprising a slowly digestible or digestion resistant carbohydrate composition |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
CN101095693B (zh) * | 2006-06-29 | 2010-10-13 | 重庆华邦制药股份有限公司 | 治疗皮炎的复方药物 |
NZ599928A (en) * | 2007-05-31 | 2012-08-31 | Glycan Biosciences | Use of pentosan polysulfate for treatment or prophylaxis of asthma |
CN109568740B (zh) | 2008-06-13 | 2022-05-27 | 曼金德公司 | 干粉吸入器和用于药物输送的系统 |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2904623T3 (es) | 2008-06-20 | 2022-04-05 | Mannkind Corp | Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación |
TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
US9050275B2 (en) * | 2009-08-03 | 2015-06-09 | Theta Biomedical Consulting & Development Co., Inc. | Methods of screening for and treating autism spectrum disorders and compositions for same |
US9176146B2 (en) * | 2009-08-03 | 2015-11-03 | Theta Biomedical Consulting & Development Co., Inc. | Methods of treating autism spectrum disorders and compositions for same |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
WO2011068721A1 (en) * | 2009-12-03 | 2011-06-09 | Opko Health, Inc. | Hypersulfated disaccharide formulations |
US20110212181A1 (en) * | 2010-02-26 | 2011-09-01 | The University Of Hong Kong | Compositions and methods for treating chronic respiratory inflammation |
KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
JP2014500863A (ja) * | 2010-10-29 | 2014-01-16 | オプコ ヘルス インコーポレイテッド | エラスターゼ関連障害を治療するための高硫酸化二糖 |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
UY34069A (es) * | 2011-05-12 | 2013-01-03 | Aventis Pharma Sa | Semuloparina para la prevención de tromboembolismo venoso en pacientes con cáncer que están recibiendo quimioterapia |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
BR112014009686A2 (pt) | 2011-10-24 | 2018-08-07 | Mannkind Corp | composição analgésica inalável, pó seco e método para tratar dor |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9314528B2 (en) | 2011-12-07 | 2016-04-19 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
EP2911690A1 (en) | 2012-10-26 | 2015-09-02 | MannKind Corporation | Inhalable influenza vaccine compositions and methods |
ES2754388T3 (es) | 2013-03-15 | 2020-04-17 | Mannkind Corp | Composiciones y métodos de dicetopiperazina microcristalina |
BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
EP3191091B1 (en) | 2014-09-12 | 2020-08-26 | Children's Medical Center Corporation | Dietary emulsion formulations and methods for using the same |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
NZ732058A (en) | 2014-11-25 | 2023-06-30 | Allergan Inc | Stabilized omega-3 ophthalmic compositions |
TW201815394A (zh) | 2016-08-16 | 2018-05-01 | 美商歐科製藥有限公司 | 具有改良口服生物可利用性之純七硫酸化雙醣 |
US11787783B2 (en) | 2016-12-13 | 2023-10-17 | Beta Therapeutics Pty Ltd | Heparanase inhibitors and use thereof |
RU2019121873A (ru) | 2016-12-13 | 2021-01-15 | БЕТА ТЕРАПЬЮТИКС ПиТиУай ЛТД | Ингибиторы гепараназы и их применение |
CN114053251A (zh) * | 2020-07-29 | 2022-02-18 | 苏州融析生物科技有限公司 | 硫酸化多糖吸入制剂及其在防治新冠病毒相关疾病中的应用 |
US20220211746A1 (en) * | 2021-01-07 | 2022-07-07 | Bionovax Corp. | Special heparinoid composition, with repair, prophylactic and anti-inflammatory effects, applied to the lungs |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3405120A (en) * | 1966-01-27 | 1968-10-08 | Green Cross Corp | Low molecular chondroitin sulfate and method for manufacturing the same |
IT1195497B (it) | 1983-03-08 | 1988-10-19 | Opocrin Spa | Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina |
US4847338A (en) * | 1985-03-28 | 1989-07-11 | University Of Iowa Research Foundation | Low molecular weight heparin fragments as inhibitors of complement activation |
FR2584728B1 (fr) * | 1985-07-12 | 1987-11-20 | Choay Sa | Procede de sulfatation de glycosaminoglycanes et de leurs fragments |
FR2584606A1 (fr) * | 1985-07-12 | 1987-01-16 | Dropic | Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif |
IT1230582B (it) * | 1988-10-21 | 1991-10-28 | Opocrin S P A Lab Farmabiologi | Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica |
US5380716A (en) | 1988-12-15 | 1995-01-10 | Glycomed, Inc. | Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
US5032679A (en) | 1988-12-15 | 1991-07-16 | Glycomed, Inc. | Heparin fragments as inhibitors of smooth muscle cell proliferation |
DE69232615T2 (de) * | 1991-05-02 | 2003-01-30 | Cohen, Irun R. | Zusammensetzungen zur verhütung und/oder behandlung von pathologischen prozessen |
WO1994018988A2 (en) * | 1993-02-22 | 1994-09-01 | Von Arnim Ulrich Christoph | Use of heparins for the treatment of inflammatory or immunological diseases |
FR2704861B1 (fr) * | 1993-05-07 | 1995-07-28 | Sanofi Elf | Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant. |
US5527785A (en) * | 1993-05-14 | 1996-06-18 | The Regents Of The University Of California | Selectin receptor modulating compositions |
SE9303612D0 (sv) * | 1993-11-02 | 1993-11-02 | Kabi Pharmacia Ab | New use |
US5690910A (en) * | 1995-08-18 | 1997-11-25 | Baker Norton Pharmaceuticals, Inc. | Method for treating asthma |
-
1997
- 1997-08-04 US US08/904,565 patent/US5980865A/en not_active Expired - Lifetime
-
1998
- 1998-04-08 UA UA2000020607A patent/UA75022C2/uk unknown
- 1998-07-31 ZA ZA986890A patent/ZA986890B/xx unknown
- 1998-08-03 AR ARP980103829A patent/AR005221A1/es not_active Application Discontinuation
- 1998-08-04 NZ NZ502498A patent/NZ502498A/en not_active IP Right Cessation
- 1998-08-04 DK DK98938290T patent/DK1003479T3/da active
- 1998-08-04 CN CN98808919A patent/CN1092049C/zh not_active Expired - Fee Related
- 1998-08-04 DE DE69834256T patent/DE69834256T2/de not_active Expired - Lifetime
- 1998-08-04 AU AU86846/98A patent/AU8684698A/en not_active Abandoned
- 1998-08-04 AT AT98938290T patent/ATE323500T1/de active
- 1998-08-04 KR KR1020007001123A patent/KR100551773B1/ko not_active IP Right Cessation
- 1998-08-04 BR BR9811823-4A patent/BR9811823A/pt not_active Application Discontinuation
- 1998-08-04 WO PCT/US1998/016111 patent/WO1999006025A1/en not_active Application Discontinuation
- 1998-08-04 JP JP2000504840A patent/JP2001511439A/ja not_active Withdrawn
- 1998-08-04 HU HU0003013A patent/HUP0003013A3/hu unknown
- 1998-08-04 CA CA002298445A patent/CA2298445C/en not_active Expired - Fee Related
- 1998-08-04 PT PT98938290T patent/PT1003479E/pt unknown
- 1998-08-04 ES ES98938290T patent/ES2260843T3/es not_active Expired - Lifetime
- 1998-08-04 IL IL13423098A patent/IL134230A0/xx unknown
- 1998-08-04 RU RU2000105383/14A patent/RU2209624C2/ru not_active IP Right Cessation
- 1998-08-04 EP EP98938290A patent/EP1003479B1/en not_active Expired - Lifetime
- 1998-08-04 PL PL338551A patent/PL191796B1/pl unknown
- 1998-08-04 SK SK117-2000A patent/SK1172000A3/sk unknown
- 1998-08-05 TW TW087112755A patent/TW585771B/zh not_active IP Right Cessation
-
1999
- 1999-05-04 US US09/304,814 patent/US6193957B1/en not_active Expired - Lifetime
-
2000
- 2000-02-03 NO NO20000558A patent/NO20000558L/no not_active Application Discontinuation
-
2001
- 2001-02-23 HK HK01101310A patent/HK1030370A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK1172000A3 (en) | Method and compositions for treating late phase allergic reactions and inflammatory diseases | |
JP3263723B2 (ja) | 喘息を治療するための組成物、及び喘息にかかった患者を治療するための気管支内薬物の製造における超低分子量ヘパリンの使用 | |
JP4585121B2 (ja) | 薬剤療法に対する寛容を予防するための方法と組成物 | |
WO1993019734A1 (en) | Method and composition for treating antigen-induced and exercise-induced asthma | |
AU775161B2 (en) | Method and compositions for treating late phase allergic reactions and inflammatory diseases | |
RU2179445C2 (ru) | Способ и композиция для лечения астмы | |
MXPA00000992A (en) | Method and compositions for treating late phase allergic reactions and inflammatory diseases | |
MXPA98001165A (en) | Method and composition for the treatment of the | |
CZ2000426A3 (cs) | Farmaceutický přípravek k léčení pozdní fáze alergické reakce a zánětlivé nemoci | |
EP1462148A2 (en) | Methods and compositions for the prevention of tolerance to bronchodilators |